VRA Amex mit interessanten News ! - 500 Beiträge pro Seite

[freshmeat]

Mit gestriger (28.12.) News und Filing, kann man mit der Aktie schön ins Jahr 2007 starten meiner Meinung nach.

Na ich hoffe, Ihr informiert Euch noch rechtzeitig und wünsche Euch allen einen guten Rutsch!

Hier die News
Viragen licenses Aussie drug rights
Thursday December 28, 4:39 pm ET


Though it does not yet have government permission to sell the product, Viragen has granted exclusive marketing, sales and distribution rights for its melanoma treatment in Australia and New Zealand - the areas that report the highest melanoma incidence rates in the world.

Once Viragen (AMEX: VRA - News) gets regulatory approval in those sites, it estimated the agreement to be worth up to $10 million to $15 million a year once it also gets reimbursement authorization.

The company's new partner, Orphan Australia, is to be responsible for getting those regulatory approvals. Viragen targeted the regulatory process in Australia to take about 12-18 months.

So far, Multiferon is approved in Sweden for first-line adjuvant treatment of high-risk malignant melanoma. Viragen has said it is proceeding with a regulatory strategy targeting approvals throughout the broader European Union.

Until then, clinicians who demand Multiferon for their patients should be able to get it on a "named-patient" basis according to the local mechanisms for such supply.

The Plantation-based biotech and its Viragen International (OTCBB: VGNI - News) subsidiary said Orphan Australia is to begin its official rights for Multiferon by focusing marketing efforts for treatment of high-risk malignant melanoma.

Viragen said the agreement provides it an up-front license fee and additional milestone payments upon receipt of reimbursement authorization for Multiferon in Australia and possibly other countries to be added later.

Open Australia said it has the potential to expand its relationship with Viragen into countries throughout the Pacific/Asia region. It is to be Open Australia's job to determine the most appropriate manner to enter those regional countries.

"The likelihood of being diagnosed with melanoma in Australia is four-fold higher than in the U.S. or Europe, so this is a very important market opportunity, and we look forward to working closely with Orphan Australia to position Multiferon as a therapy option that will be preferred by physicians and patients," said Viragen President and Chief Executive Officer Charles A. Rice.

Alastair Young, Orphan Australia managing director, said demand for a promising new melanoma treatment is high.

"The current standard-of-care for high-risk malignant melanoma is surgical treatment and no effective adjuvant treatment currently exists, which leaves this patient category wide open for new, effective products," he said. "We are extremely excited regarding our ability to market Multiferon as an emerging, leading adjuvant treatment for this indication with excellent prospects to significantly improve patients' survival rates, and we believe there could be ample opportunities for this important product in other oncology indications as well."

Viragen shares closed up a penny, or 6.25 percent, to 17 cents. The 52-week high was 80 cents on Feb. 21. The 52-week low was 14 cents on Dec. 13.

Viragen International shares also closed up a penny, a 20 percent increase, to 6 cents. The 52-week high was 23 cents on March 27. The 52-week low was 5 cents on Wednesday.

Published December 28, 2006 by the South Florida Business Journal

[Schablonski]

heute auch mal endlich wieder mit ordentlichem Plus.
Gestern im Reuters-Report erwähnt und heute weiter positive News

[Schablonski]

heute geht es wieder los...vorbörslich 0,19

[Schablonski]

puuuuuuuuuuuuh....80% Minus heute nachdem 93 Millionen Aktien ausgegeben wurden. Das ist doch gnadenlos übertrieben

[freshmeat]

Hmm bin auch etwas ratlos .... um ehrlich zu sein

[freshmeat]

Hmm, also man bemüht sich mit allen Regeln der Kunst an der Amex zu bleiben. Das scheint nun auch in trockenen Tüchern zu sein.... Ich habe da auch so ein bissl den Verdacht das absichtlich "umgeschichtet" wurde. Jedenfalls könnte ich mir vorstellen, dass es jetzt langsam und stetig aufwärts geht. In FRA wurde zwischendurch auch mal von jemanden ordentlich zugelangt und ich glaube nicht das dies aus jux geschehen ist....


Gruss Fresh


Alles meine pers. Meinung.... jeder Handelt selbst und muss sich seine eigene Meinung bilden...